Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignancies

NCT00079391 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

NIH

Sponsor class

Conditions

Hematologic Malignancies
Bone Marrow Transplant Rejection

Interventions

DEVICE: allogeneic hematopoietic stem cell transplantation

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)